These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1687761)

  • 21. Zacopride and BRL 24924 induce an increase in EEG-energy in rats.
    Boddeke HW; Kalkman HO
    Br J Pharmacol; 1990 Oct; 101(2):281-4. PubMed ID: 2257436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-ranging trial of zacopride: the emetic antiemetic?
    Pisters KM; Kris MG; Tyson LB; Clark RA; Gralla RJ
    J Natl Cancer Inst; 1992 May; 84(9):717-8. PubMed ID: 1569606
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of chlordiazepoxide, buspirone and the 5-HT3 receptor antagonist, BRL 46470, on the behaviour of oestrous and dioestrous female mice when encountering male partners.
    Gao B; Cutler MG
    Neuropharmacology; 1993 Oct; 32(10):969-75. PubMed ID: 7905193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?
    Nevins ME; Anthony EW
    J Pharmacol Exp Ther; 1994 Jan; 268(1):248-54. PubMed ID: 7905528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage.
    Gao B; Cutler MG
    Neuropharmacology; 1992 Aug; 31(8):743-8. PubMed ID: 1356251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antiemetic profile of zacopride.
    Smith WL; Alphin RS; Jackson CB; Sancilio LF
    J Pharm Pharmacol; 1989 Feb; 41(2):101-5. PubMed ID: 2568416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agonist effects at putative central 5-HT4 receptors in rat hippocampus by R(+)- and S(-)-zacopride; no evidence for stereo-selectivity.
    Boddeke HW; Kalkman HO
    Neurosci Lett; 1992 Jan; 134(2):261-3. PubMed ID: 1589153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buspirone enhances immobility in the forced swim test in mice.
    Kitamura Y; Nagatani T
    Pharmacol Biochem Behav; 1996 Nov; 55(3):445-51. PubMed ID: 8951987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zacopride, a potent 5-HT3 antagonist.
    Smith WW; Sancilio LF; Owera-Atepo JB; Naylor RJ; Lambert L
    J Pharm Pharmacol; 1988 Apr; 40(4):301-2. PubMed ID: 2900319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actions of buspirone in a putative model of anxiety in the mouse.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES
    J Pharm Pharmacol; 1988 Jul; 40(7):494-500. PubMed ID: 2904990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of anxiolytics in zebrafish: similarities and differences between benzodiazepines, buspirone and ethanol.
    Gebauer DL; Pagnussat N; Piato AL; Schaefer IC; Bonan CD; Lara DR
    Pharmacol Biochem Behav; 2011 Sep; 99(3):480-6. PubMed ID: 21570997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zacopride, a 5-HT3 receptor antagonist, reduces voluntary ethanol consumption in rats.
    Knapp DJ; Pohorecky LA
    Pharmacol Biochem Behav; 1992 Apr; 41(4):847-50. PubMed ID: 1594653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze.
    Zhang ZJ; Schmidt DE; de Paulis T; Trivedi BL; Onaivi ES; Ebert MH; Hewlett WA
    Pharmacol Biochem Behav; 2001; 69(3-4):571-8. PubMed ID: 11509218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice.
    Magnani P; Conforti A; Zanolin E; Marzotto M; Bellavite P
    Psychopharmacology (Berl); 2010 Jul; 210(4):533-45. PubMed ID: 20401745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute administration of diazepam and buspirone in rats trained on conflict schedules having different degrees of predictability.
    Costello NL; Carlson JN; Glick SD
    Pharmacol Biochem Behav; 1991 Dec; 40(4):787-94. PubMed ID: 1687764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [3H]zacopride binding to 5-hydroxytryptamine3 sites on partially purified rabbit enteric neuronal membranes.
    Gordon JC; Barefoot DS; Sarbin NS; Pinkus LM
    J Pharmacol Exp Ther; 1989 Dec; 251(3):962-8. PubMed ID: 2600824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of buspirone on the behaviour of control and stressed mice.
    Pokk P; Zharkovsky A
    J Physiol Pharmacol; 1998 Mar; 49(1):175-85. PubMed ID: 9594420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained 5-hydroxytryptamine release-inhibitory and anxiolytic-like action of the partial 5-HT1A receptor agonist, buspirone, after prolonged chronic administration.
    Söderpalm B; Lundin B; Hjorth S
    Eur J Pharmacol; 1993 Aug; 239(1-3):69-73. PubMed ID: 7901030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
    Briones-Aranda A; López-Rubalcava C; Picazo O
    Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological study of the light/dark preference test in zebrafish (Danio rerio): Waterborne administration.
    Magno LD; Fontes A; Gonçalves BM; Gouveia A
    Pharmacol Biochem Behav; 2015 Aug; 135():169-76. PubMed ID: 26026898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.